Literature DB >> 28932875

[Severe cutaneous drug reactions in children].

M Mockenhaupt1.   

Abstract

Among severe drug reactions in children, besides Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), a specific form of hypersensitivity syndrome which is nowadays known as "drug reaction with eosinophilia and systemic symptoms" (DRESS) has to be mentioned. Whereas SJS/TEN is considered one reaction entity of different severity, DRESS has to be distinguished from SJS/TEN but also from other severe exanthems due to multiorgan involvement. Although SJS/TEN is generally referred to as a drug reaction, only about 75% of all cases are actually caused by medications and in children it is only about 50%. After a clear diagnosis has been made, specific therapeutic measures can follow, of which withdrawal of the inducing agent plays a key role, but further treatments differ substantially. In order to identify and withdraw the inducing agent, a detailed and thorough medication history must be obtained. Highly suspected drugs of SJS/TEN in children include, among others, antibacterial sulfonamides and various antiepileptics. DRESS in children and adolescents is also frequently induced by antiepileptics, but also by sulfonamides and minocycline. In contrast to adults, allopurinol is rarely found to be culprit in both conditions. Supportive therapy including appropriate topical treatments, pain therapy, ophthalmologic consultations, etc. is the gold standard in SJS/TEN, but a short-term immunomodulating therapy with cyclosporine A has shown very promising results in recent studies. In DRESS, however, systemic treatment with glucocorticosteroids slowly tapered over a longer period of time is recommended.

Entities:  

Keywords:  Drug reaction with eosinophilia and systemic symptoms; Risk factors; Stevens-Johnson syndrome; Therapeutic management; Toxic epidermal necrolysis

Mesh:

Substances:

Year:  2017        PMID: 28932875     DOI: 10.1007/s00105-017-4048-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  32 in total

Review 1.  Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome.

Authors:  Yoko Kano; Tadashi Ishida; Kazuhisa Hirahara; Tetsuo Shiohara
Journal:  Med Clin North Am       Date:  2010-07       Impact factor: 5.456

2.  Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  L Valeyrie-Allanore; P Wolkenstein; L Brochard; N Ortonne; B Maître; J Revuz; M Bagot; J C Roujeau
Journal:  Br J Dermatol       Date:  2010-10       Impact factor: 9.302

3.  Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry.

Authors:  B Rzany; M Mockenhaupt; S Baur; W Schröder; U Stocker; J Mueller; N Holländer; R Bruppacher; E Schöpf
Journal:  J Clin Epidemiol       Date:  1996-07       Impact factor: 6.437

4.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

5.  Fever in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Cases: Laboratory Work-up and Antibiotic Therapy.

Authors:  Maren Paulmann; Maja Mockenhaupt
Journal:  Pediatr Infect Dis J       Date:  2017-05       Impact factor: 2.129

6.  Epidemiology of staphylococcal scalded skin syndrome in Germany.

Authors:  Maja Mockenhaupt; Marco Idzko; Martine Grosber; Erwin Schöpf; Johannes Norgauer
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

Review 7.  Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes.

Authors:  Manuel Florian Struck; Peter Hilbert; Maja Mockenhaupt; Beate Reichelt; Michael Steen
Journal:  Intensive Care Med       Date:  2009-09-29       Impact factor: 17.440

8.  Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy.

Authors:  Maren Paulmann; Maja Mockenhaupt
Journal:  J Dtsch Dermatol Ges       Date:  2015-07       Impact factor: 5.584

Review 9.  Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.

Authors:  Pierre-Dominique Ghislain; Jean-Claude Roujeau
Journal:  Dermatol Online J       Date:  2002-06

10.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

Authors:  Ariane Auquier-Dunant; Maja Mockenhaupt; Luigi Naldi; Osvaldo Correia; Werner Schröder; Jean-Claude Roujeau
Journal:  Arch Dermatol       Date:  2002-08
View more
  1 in total

1.  [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].

Authors:  Argyrios Chronopoulos; Maja Mockenhaupt; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-03-16       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.